Hims & Hers Health is trading at €23.54, down 3.37%, with no company-specific announcement explaining the November 5 decline found in available search results. - Its next earnings report is scheduled for November 9. - On November 4, Hims & Hers rallied with healthcare stocks after election results eased policy uncertainty; that move does not explain the current decline. - The supplied healthcare-sector trend is positive, but does not establish a same-direction catalyst for the drop.